PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-16.27%
Both companies show declining revenue. Martin Whitman would check for industry-wide issues.
-14.19%
Cost reduction while VET shows 10.20% growth. Joel Greenblatt would examine competitive advantage.
-18.09%
Both companies show declining gross profit. Martin Whitman would check industry conditions.
-2.17%
Both companies show margin pressure. Martin Whitman would check industry conditions.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
6.12%
Other expenses growth less than half of VET's 100.00%. David Dodd would verify if advantage is sustainable.
5.70%
Operating expenses growth above 1.5x VET's 3.63%. Michael Burry would check for inefficiency.
-7.48%
Total costs reduction while VET shows 5.70% growth. Joel Greenblatt would examine advantage.
No Data
No Data available this quarter, please select a different quarter.
14.03%
D&A growth above 1.5x VET's 0.78%. Michael Burry would check for excessive investment.
-17.90%
Both companies show EBITDA decline. Martin Whitman would check industry conditions.
-3.43%
Both companies show margin pressure. Martin Whitman would check industry conditions.
-37.33%
Both companies show declining income. Martin Whitman would check industry conditions.
-25.16%
Both companies show margin pressure. Martin Whitman would check industry conditions.
-18.15%
Other expenses reduction while VET shows 47.55% growth. Joel Greenblatt would examine advantage.
-34.54%
Pre-tax income decline while VET shows 483866.67% growth. Joel Greenblatt would examine position.
-21.82%
Pre-tax margin decline while VET shows 526327.14% growth. Joel Greenblatt would examine position.
-149.12%
Both companies reducing tax expense. Martin Whitman would check patterns.
-7.16%
Net income decline while VET shows 4634.58% growth. Joel Greenblatt would examine position.
10.87%
Net margin growth below 50% of VET's 5032.43%. Michael Burry would check for structural issues.
19.09%
EPS growth below 50% of VET's 4340.00%. Michael Burry would check for structural issues.
19.36%
Diluted EPS growth below 50% of VET's 4340.00%. Michael Burry would check for structural issues.
-7.63%
Share count reduction while VET shows 0.39% change. Joel Greenblatt would examine strategy.
-8.96%
Diluted share reduction while VET shows 0.05% change. Joel Greenblatt would examine strategy.